High-throughput screening and cellular analysis instruments for drug discovery and life sciences research
Molecular Devices manufactures scientific instruments and software platforms for high-throughput screening, genomic analysis, and microplate detection—tools embedded in over 160,000 laboratory setups worldwide. The hiring profile skews heavily toward sales (26 roles) and finance (9), with minimal engineering capacity (2 roles), reflecting a mature hardware and software vendor model where go-to-market execution and operational efficiency drive growth. Active projects signal a shift toward cellular workflow automation and aftermarket revenue expansion, while pain points centered on supplier delays and working capital point to supply-chain and margin pressure typical of capital-equipment businesses.
Notable leadership hires: Finance Director, Sourcing Director
Molecular Devices is a publicly traded life sciences instrumentation company founded in 1983 and now owned by Danaher. Headquartered in San Jose, California, the company operates with 1,001–5,000 employees across the United States, Europe, and Asia. The product portfolio spans high-throughput screening systems, microplate readers, electrophysiology platforms, and data acquisition software—all targeted at pharmaceutical, biotech, and academic research institutions. The company's instruments have contributed to work described in over 230,000 peer-reviewed publications. Current strategic initiatives include launching new products, expanding aftermarket sales channels, integrating Danaher solutions, and automating cellular workflows. Global hiring spans nine countries, with concentrated efforts in the United States, China, India, and Western Europe.
Molecular Devices uses Salesforce, Oracle ERP, AWS, Jira, Bitbucket, and development languages including C#, C++, TypeScript, and Angular. Documentation is authored in MadCap Flare and FrameMaker; design tools include Adobe Creative Suite and SolidWorks.
Molecular Devices actively hires in nine countries: United States, China, United Kingdom, Austria, Germany, India, South Korea, and Japan, with notable localization programs underway in China.
Other companies in the same industry, closest in size